Correlation Between Talaris Therapeutics and Design Therapeutics
Can any of the company-specific risk be diversified away by investing in both Talaris Therapeutics and Design Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Talaris Therapeutics and Design Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Talaris Therapeutics and Design Therapeutics, you can compare the effects of market volatilities on Talaris Therapeutics and Design Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Talaris Therapeutics with a short position of Design Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Talaris Therapeutics and Design Therapeutics.
Diversification Opportunities for Talaris Therapeutics and Design Therapeutics
0.37 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Talaris and Design is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Talaris Therapeutics and Design Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Design Therapeutics and Talaris Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Talaris Therapeutics are associated (or correlated) with Design Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Design Therapeutics has no effect on the direction of Talaris Therapeutics i.e., Talaris Therapeutics and Design Therapeutics go up and down completely randomly.
Pair Corralation between Talaris Therapeutics and Design Therapeutics
Given the investment horizon of 90 days Talaris Therapeutics is expected to generate 0.89 times more return on investment than Design Therapeutics. However, Talaris Therapeutics is 1.13 times less risky than Design Therapeutics. It trades about 0.12 of its potential returns per unit of risk. Design Therapeutics is currently generating about 0.01 per unit of risk. If you would invest 142.00 in Talaris Therapeutics on August 24, 2024 and sell it today you would earn a total of 156.00 from holding Talaris Therapeutics or generate 109.86% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 32.06% |
| Values | Daily Returns |
Talaris Therapeutics vs. Design Therapeutics
Performance |
| Timeline |
| Talaris Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Design Therapeutics |
Talaris Therapeutics and Design Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Talaris Therapeutics and Design Therapeutics
The main advantage of trading using opposite Talaris Therapeutics and Design Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Talaris Therapeutics position performs unexpectedly, Design Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Design Therapeutics will offset losses from the drop in Design Therapeutics' long position.| Talaris Therapeutics vs. Edgewise Therapeutics | Talaris Therapeutics vs. Adicet Bio | Talaris Therapeutics vs. Cullinan Oncology LLC | Talaris Therapeutics vs. Vor Biopharma |
| Design Therapeutics vs. Monte Rosa Therapeutics | Design Therapeutics vs. Werewolf Therapeutics | Design Therapeutics vs. Ikena Oncology | Design Therapeutics vs. Stoke Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Stocks Directory Find actively traded stocks across global markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |